Hubble Therapeutics
Hubble Therapeutics is pioneering novel ion channel gene therapies to restore vision.
Employees
Enterprise value
$29—44m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
* | $7.3m | Series A | |
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads